Video

Myelofibrosis: Novel Treatment Strategies and Combination Therapies

Author(s):

Ruben Mesa, M.D.,Rami S. Komrokji, M.D.

Comprehensive discussion on the management of myelofibrosis, covering both monotherapy and combination therapy strategies.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of a man with text.
Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost independence from blood transfusions.
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
Related Content
Image of a patient undergoing chemotherapy
August 19th 2025

Intensive Chemotherapy Boosts Survival in Patients With Advanced MPNs

Spencer Feldman
Cancer Horizons podcast logo
August 19th 2025

FDA Stops Lung Cancer Trial, CAR-T Cell Therapy Is Cost Effective, Novel Drug Slows Fibrosis

Alex Biese Brielle Benyon
Image of blood.
August 19th 2025

July Blood Cancer Highlights: Top 5 Updates Patients Should Know

Ryan Scott
LeVar Burton Helping the MPN Community Through Advocacy and Storytelling
August 19th 2025

LeVar Burton Helping the MPN Community Through Advocacy and Storytelling

Jamie Cesanek Darlene Dobkowski, MA
Image of doctor
August 19th 2025

What Patients With Polycythemia Vera Should Know After ASCO 2025

Dr. Joshua K. Sabari Dr. Raajit K. Rampal
The FDA granted fast track designation to nuvisertib for those with intermediate or high-risk myelofibrosis: © stock.adobe.com.
August 19th 2025

FDA Grants Fast Track Designation to Nuvisertib in Myelofibrosis

Spencer Feldman